Crestor Combination Treatment Shows Unprecedented 70% LDL-C Reduction

A combination of rosuvastatin and ezetimibe achieved the largest reduction in LDL-C ever seen in a statin trial, AstraZeneca says.

More from Archive

More from Pink Sheet